We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01130519
Brief Title: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

First Submitted : May 25, 2010
First Submitted that Met QC Criteria : May 25, 2010
First Posted : May 26, 2010 (Estimate)

Last Update Submitted : January 10, 2018
Last Update Submitted that Met QC Criteria : January 10, 2018
Last Update Posted : January 11, 2018 (Estimate)